Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

NARecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

October 31, 2024

Conditions
LymphomaMultiple Myeloma
Interventions
DRUG

Etoposide

Day 1\~Day 2: 75mg/m\^2

DRUG

Cytarabine

Day 1\~Day 2: 200mg/m\^2, q12h

DRUG

PEG-rhG-CSF

Day 6: 6mg

Trial Locations (14)

310012

RECRUITING

Tongde Hospital of Zhejiang Province, Hangzhou

310024

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

312000

RECRUITING

Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing

312099

RECRUITING

Shaoxing Second Hospital, Shaoxing

315040

RECRUITING

The Affiliated People's Hospital of Ningbo University, Ningbo

317099

RECRUITING

Taizhou Hospital of Zhejiang Province, Taizhou

321000

RECRUITING

Jinhua Municipal Central Hospital, Jinhua

321099

RECRUITING

Jinhua People's Hospital, Jinhua

323000

RECRUITING

Lishui Municipal Central Hospital, Lishui

Unknown

RECRUITING

Dongyang People's Hospital, Dongyang

RECRUITING

Huzhou central hospital, Huzhou

RECRUITING

Ningbo Medical Center Lihuili Hospital, Ningbo

RECRUITING

Taizhou Central Hospital, Taizhou

RECRUITING

The 2nd School of Medicine,WMU/The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU, Wenzhou

All Listed Sponsors
lead

The Affiliated People's Hospital of Ningbo University

OTHER_GOV